{
    "ticker": "ACIU",
    "name": "Aciuk Pharmaceuticals, Inc.",
    "description": "Aciuk Pharmaceuticals, Inc. is a biotechnology company focused on the development of innovative therapies for the treatment of serious and life-threatening diseases. Founded in 2013, Aciuk is dedicated to advancing the field of medicine through research and development of novel biologics and small molecule drugs. The company is particularly known for its work in immunotherapy and targeted therapies aimed at enhancing the body's immune response to fight cancer and infectious diseases. Aciuk's pipeline includes several promising candidates in various stages of clinical trials, focusing on improving efficacy and patient outcomes. The company collaborates with academic institutions and research organizations to leverage cutting-edge science and technology in its drug development efforts. Aciuk Pharmaceuticals is committed to bringing transformative treatments to patients while maintaining high standards of safety and efficacy. With a mission to address unmet medical needs, Aciuk strives to make a significant impact on healthcare and improve the quality of life for patients worldwide.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Cambridge, Massachusetts, USA",
    "founded": "2013",
    "website": "https://www.aciukpharma.com",
    "ceo": "Dr. Jane Smith",
    "social_media": {
        "twitter": "https://twitter.com/AciukPharma",
        "linkedin": "https://www.linkedin.com/company/aciuk-pharmaceuticals/"
    },
    "investor_relations": "https://ir.aciukpharma.com",
    "key_executives": [
        {
            "name": "Dr. Jane Smith",
            "position": "CEO"
        },
        {
            "name": "John Doe",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology",
            "products": [
                "AC-101",
                "AC-202"
            ]
        },
        {
            "category": "Infectious Diseases",
            "products": [
                "AC-303"
            ]
        }
    ],
    "seo": {
        "meta_title": "Aciuk Pharmaceuticals, Inc. | Innovative Therapies for Serious Diseases",
        "meta_description": "Explore Aciuk Pharmaceuticals, Inc., a biotechnology leader developing novel therapies for cancer and infectious diseases. Learn about our innovative approach and pipeline.",
        "keywords": [
            "Aciuk Pharmaceuticals",
            "Biotechnology",
            "Immunotherapy",
            "Cancer Treatment",
            "Innovative Drugs"
        ]
    },
    "faq": [
        {
            "question": "What does Aciuk Pharmaceuticals specialize in?",
            "answer": "Aciuk Pharmaceuticals specializes in developing innovative therapies for serious and life-threatening diseases, including cancer and infectious diseases."
        },
        {
            "question": "Who is the CEO of Aciuk Pharmaceuticals?",
            "answer": "Dr. Jane Smith is the CEO of Aciuk Pharmaceuticals, Inc."
        },
        {
            "question": "Where is Aciuk Pharmaceuticals headquartered?",
            "answer": "Aciuk Pharmaceuticals is headquartered in Cambridge, Massachusetts, USA."
        },
        {
            "question": "What are the main products of Aciuk Pharmaceuticals?",
            "answer": "Aciuk Pharmaceuticals' main products include AC-101, AC-202 for oncology, and AC-303 for infectious diseases."
        },
        {
            "question": "When was Aciuk Pharmaceuticals founded?",
            "answer": "Aciuk Pharmaceuticals was founded in 2013."
        }
    ],
    "competitors": [
        "AMGN",
        "REGN",
        "BMY",
        "GILD"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRNA",
        "NVAX"
    ]
}